AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat

AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat

Submitted by admin on October 30, 2024 - 8:50pm
Source: 
Investors Business Daily
News Tags: 
AbbVie
earnings
Humira
Skyrizi
Headline: 
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
snippet: 

AbbVie (ABBV) stock popped Wednesday after the pharma behemoth's new king in immunology finally outpaced its grandfather drug, Humira.

Do Not Allow Advertisers to Use My Personal information